Study details
Enrolling now
Prevent Cardiac Surgery Associated AKI Trial
George Washington University
NCT IDNCT06620523ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
242
Study length
about 3.9 years
Ages
18–70
Locations
1 site in DC
What this study is about
This trial is testing if CoQ10 and Glutathione can help prevent kidney problems after heart surgery. Patients undergoing elective cardiopulmonary bypass surgery will receive either a placebo or daily doses of CoQ10, Glutathione, or both. Blood and urine samples will be collected to monitor the effects.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take CoQ10 1200 mg orally with Glutathione 1000 mg orally
- 2.Take Group B: Placebo CoQ10 orally and Placebo Glutathione orally
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
OralOral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
VARIOUS
Drug routes
oral
Body systems
Renal, Cardiology / Heart